The excursion of defying cellular breakdown in the lungs reaches out past the actual domain; it's complicatedly entwined with a heap of feelings. From

Dec 18 () - Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using ​artificial intelligence, succeeded in two late-stage studies. More than half ‌the plaque psoriasis patients across the studies showed clear or almost clear skin after ‌16 weeks of treatment with the once-daily drug, zasocitinib, the company said.

Those signs about surprise insurance charges are intended to keep patients informed – but new research points to a negative side effect.